Skip to main content

Caris Life Sciences: Joseph Gilliam

Caris Life Sciences has appointed Joseph Gilliam to serve on its board of directors, effective April 12. Following his appointment, the company's board will have 10 directors.

Gilliam is the current CFO and senior vice president of corporate development for Glaukos, where he has served since May 2017. Prior to joining Glaukos, Gilliam held various roles at JPMorgan over the course of nearly 20 years. His prior experience includes positions at the Beacon Group and PricewaterhouseCoopers. 

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.